Refer to this convenient resource for a quick overview of TALVEY®.
Refer to this convenient resource for a quick overview of TALVEY®.
Provides an overview of TALVEY®, including instructions for preparation, dosing and administration details, and adverse reaction management.
Provides an overview of TALVEY®, including instructions for preparation, dosing and administration details, and adverse reaction management.
Provides an overview of the MOA of TALVEY® and the role GPRC5D plays in multiple myeloma.
Provides an overview of the MOA of TALVEY® and the role GPRC5D plays in multiple myeloma.
Effectively managing multiple myeloma treatment greatly benefits from hands-on knowledge. In this podcast made for healthcare professionals, you’ll hear guidance and personal experiences from experts caring for patients living with multiple myeloma. Learn by example from patient case studies and conversations designed to educate about TALVEY® eligibility, AR management, dosing and transition of care.
EPISODE 1
Experts discuss TALVEY® and the unmet need in 5L+ RRMM
Experts discuss TALVEY® and the unmet need in 5L+ relapsed or refractory multiple myeloma
FEATURING Donna Catamero,
EPISODE 2
TALVEY® adverse event profile and management
Check out expert recommendations for effectively managing adverse events associated with TALVEY® safety profile
FEATURING Samantha Shenoy, MSN, NP, University of California, San Francisco (UCSF)
EPISODE 3
The TALVEY® patient journey from dosing to transitions of care
Explore TALVEY® dosing options and learn about transitioning patients from inpatient to outpatient settings
FEATURING Dennis Verducci,
Currently playing:
Experts discuss TALVEY® and the unmet need in 5L+ relapsed or refractory multiple myeloma
FEATURING Donna Catamero,
AR, adverse reaction; GPRC5D, G protein-coupled receptor class C group 5 member D; HCP, healthcare provider; MOA, mechanism of action; RRMM, relapsed or refractory multiple myeloma; 5L+, patients treated with 4 or more prior lines of therapy.
Coping tips are available to counsel patients on select adverse reactions. The recommendations below from The Leukemia & Lymphoma Society and the American Cancer Society may help patients better cope with select adverse reactions they may be experiencing. For more tips, please see lls.org and cancer.org.
The following recommendations from The Leukemia & Lymphoma Society and the American Cancer Society may help patients experiencing oral toxicities. For more tips, please visit lls.org and cancer.org.
Nail changes1,2
These may include a change in the appearance of the nail (including koilonychia, nail discoloration, and nail pitting or ridging), nail cuticle fissure, nail toxicity, or nail loss. These are not all nail changes that may occur.
Tips for patients with nail changes
For more information from The Leukemia & Lymphoma Society, review the following resource:
Side Effect Management: Caring for Skin, Nails, Hair, and Mouth
The following recommendations from The Leukemia & Lymphoma Society and the American Cancer Society may help patients experiencing oral toxicities. For more tips, please visit lls.org and cancer.org.
Skin changes1,2
These may include skin problems, itchy or red skin or raised rash, abnormally dry skin that may affect the mouth and eyes, thickening of the skin and/or redness, swelling, and blistering on the palms of hands and soles of feet, skin discoloration, peeling, dried and cracked skin, rash with acne-like bumps or blisters, or itchy skin.
Tips for patients with skin changes
For more information from The Leukemia & Lymphoma Society, review the following resource:
Side Effect Management: Caring for Skin, Nails, Hair, and Mouth
The following recommendations from The Leukemia & Lymphoma Society and the American Cancer Society may help patients experiencing oral toxicities. For more tips, please visit lls.org and cancer.org.
Oral side effects1-3
These may include dysgeusia (change in sense of taste), dry mouth, difficulty swallowing, and sores in the mouth.
Tips for patients with oral side effects
For more information from The Leukemia & Lymphoma Society, review the following resources:
The following recommendations from The Leukemia & Lymphoma Society and the American Cancer Society may help patients experiencing oral toxicities. For more tips, please visit lls.org and cancer.org.
Weight loss1,4,5
During treatment, monitor weight. A consultation with a nutritionist may be considered for supportive care.
Tips for patients with weight loss
For more information from The Leukemia & Lymphoma Society, review the following resource:
Side Effect Management: Managing Low Appetite and Weight Loss
ARs, adverse reactions.